Immunotherapy using Histobulin™ in psoriasis: A case report

被引：0

作者：

Kim, Hyuk Soon ^{[1
,2
]}

Noh, Geunwoong ^{[3
]}

机构：

[1] Dong A Univ Busan, Dept Biomed Sci, Coll Nat Sci, Busan, South Korea

[2] Dong A Univ Busan, Dept Hlth Sci, Coll Nat Sci, Busan, South Korea

[3] Cheju Halla Gen Hosp, Allergy & Clin Immunol Ctr, Jeju Si, South Korea

来源：

CLINICAL CASE REPORTS | 2022年 / 10卷 / 05期

基金：

新加坡国家研究基金会;

关键词：

biologics; Histobulin (TM); immunoglobulin; histamine complex/immunotherapy; psoriasis; ATOPIC-DERMATITIS; PATHOGENESIS; HISTAMINE; URTICARIA; DISEASES; CELLS;

D O I：

10.1002/ccr3.5831

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

There is no cure for psoriasis. A psoriasis patient was treated with Histobulin (TM). The patient's clinical symptoms and signs disappeared after the eighth injection and did not recur for more than 18 months. Histobulin (TM) was effective in the treatment of psoriasis and is suggested as a curative therapeutic for psoriasis.

引用

页数：7

共 36 条

[1] The anti-allergic drug histaglobin inhibits NF-κB nuclear translocation and down-regulates proinflammatory cytokines [J].